rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
17
|
pubmed:dateCreated |
2010-9-2
|
pubmed:abstractText |
Matrix metalloproteinase-9 (MMP-9) expression is known to enhance the invasion and metastasis of tumor cells. In previous work based on a proteomic screen, we identified the serpin protease nexin-1 (PN-1) as a potential target of MMP-9. Here, we show that PN-1 is a substrate for MMP-9 and establish a link between PN-1 degradation by MMP-9 and regulation of invasion. PN-1 levels increased in prostate carcinoma cells after downregulation of MMP-9 and in tissues of MMP-9-deficient mice, consistent with PN-1 degradation by MMP-9. We identified three MMP-9 cleavage sites in PN-1 and showed that mutations in those sites made PN-1 more resistant to MMP-9. Urokinase plasminogen activator (uPA) is inhibited by PN-1. MMP-9 augmented uPA activity in the medium of PC3-ML cells by degrading PN-1. Prostate cancer cells, overexpressing PN-1 or treated with MMP-9 shRNA, had reduced cell invasion in Matrigel. PN-1 siRNA restored uPA activity and the invasive capacity. PN-1 mutated in the serpin inhibitory domain, the reactive center loop, failed to inhibit uPA and to reduce Matrigel invasion. This study shows a novel molecular pathway in which MMP-9 regulates uPA activity and tumor cell invasion through cleavage of PN-1.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Protein Precursor,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Protease Nexins,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cell Surface,
http://linkedlifedata.com/resource/pubmed/chemical/SERPINE2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Serpin E2,
http://linkedlifedata.com/resource/pubmed/chemical/Serpine2 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Serpins,
http://linkedlifedata.com/resource/pubmed/chemical/Urokinase-Type Plasminogen Activator
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1538-7445
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6988-98
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:20736374-Amyloid beta-Protein Precursor,
pubmed-meshheading:20736374-Animals,
pubmed-meshheading:20736374-Cell Line, Tumor,
pubmed-meshheading:20736374-Humans,
pubmed-meshheading:20736374-Male,
pubmed-meshheading:20736374-Matrix Metalloproteinase 9,
pubmed-meshheading:20736374-Mice,
pubmed-meshheading:20736374-Mice, Inbred C57BL,
pubmed-meshheading:20736374-Mice, Knockout,
pubmed-meshheading:20736374-Neoplasm Invasiveness,
pubmed-meshheading:20736374-Prostatic Neoplasms,
pubmed-meshheading:20736374-Protease Nexins,
pubmed-meshheading:20736374-RNA, Small Interfering,
pubmed-meshheading:20736374-Receptors, Cell Surface,
pubmed-meshheading:20736374-Serpin E2,
pubmed-meshheading:20736374-Serpins,
pubmed-meshheading:20736374-Urokinase-Type Plasminogen Activator
|
pubmed:year |
2010
|
pubmed:articleTitle |
Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1.
|
pubmed:affiliation |
Gray Institute of Radiation Oncology and Biology, University of Oxford, Oxford, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|